Chattem Acquires “Great Brands” In Wake Of J&J’s Pfizer Purchase
This article was originally published in The Tan Sheet
Executive Summary
Chattem said its past experience with brands such as Icy Hot and Selsun Blue will make for an easier transition of its newest package acquisition
You may also be interested in...
Chattem’s Dexatrim Looks For Cost-Conscious Consumers Unfriendly To Alli
Chattem has not delivered a counter-punch to GlaxoSmithKline's alli, but the firm sees its Dexatrim supplement as "the only one left standing" to compete in the nonprescription weight-loss product category
Chattem Sales Up 51% Behind Ongoing Push From J&J Acquisitions
Brands Chattem acquired from Johnson & Johnson and continued growth of its own Gold Bond and Icy Hot drove a 51 percent increase in third-quarter revenues, the firm reported Sept. 27
Pfizer Buy Pushes Double-Digit Growth For J&J Consumer Product Sales
Johnson & Johnson's consumer products sales jumped 48.5 percent to $3.49 billion in the firm's first fiscal quarter since closing its acquisition of Pfizer Consumer Healthcare